Mint Med Review

Mint Med: one flat price for every dose, no membership attached

Mint Med is a national, direct-to-consumer telehealth platform built around a single idea that makes it genuinely easy to evaluate: you pay one flat monthly price for compounded semaglutide or tirzepatide, and that price does not change as you titrate up. There's no membership, no per-tier ladder, and no subscription you have to argue your way out of. For people who have been burned by GLP-1 platforms that advertise a low starter rate and then quietly raise the bill every time the dose increases, that flat structure is the whole pitch — and it largely holds up against the record we verified.

One important housekeeping note before anything else: Mint Med (mintmed.com) is not the same company as Mint Medical Clinic, a Utah-only in-clinic med spa that we list separately. They share a name and nothing else. Mint Med is a national, online-only operation; if you landed here looking for the Utah hybrid clinic, you want a different listing.

How the pricing actually works

The model is refreshingly literal: Mint Med charges the same monthly rate whether you're on a low starter dose or a much higher maintenance dose. Many competitors structure their plans so the headline number only applies to the lowest tier, then escalate well past two hundred dollars a month as you move up — Mint Med deliberately doesn't. At roughly $117/month effective with its introductory pricing, it sits below the $169/month category median we track, and there's a first-six-weeks promotional code that drops your entry cost further. That intro rate is a teaser, so budget around the standard flat rate as your real long-term number rather than the promo figure.

• Flat 'all doses' pricing — the monthly cost is the same on your starting dose and your maintenance dose
• No membership fee layered on top — it's genuinely pay-as-you-go, month to month
• A first-six-weeks promotional code lowers your initial cost before the standard rate kicks in
• HSA/FSA eligible, which is uncommon for compounded GLP-1 platforms and can stretch your dollars further
• Cancel anytime with 48 business hours' notice before your next order ships

The medications, and how they reach you

Mint Med offers two compounded injectables: semaglutide (the molecule in Wegovy and Ozempic) and tirzepatide (the molecule in Zepbound and Mounjaro). Both carry the same flat monthly price, so you can choose between them on clinical fit rather than cost. There's no oral version and no liraglutide. Crucially, these are compounded medications, not brand-name pens — Mint Med publishes the FDA's standard disclaimer that compounded drugs are made for individual patients and are not FDA-reviewed for safety or effectiveness, and that a valid prescription is required. That's the honest, correct framing, and we credit them for putting it on the homepage instead of burying it.

Intake runs through asynchronous telehealth in states that allow it — you complete a questionnaire and a licensed U.S.-based clinician reviews it, rather than scheduling a live video visit. That makes onboarding fast, but it's a trade-off: if you want a real-time conversation with the prescriber before starting, this isn't the model that gives it to you.

What actually sets it apart

The flat all-doses price is the real differentiator, and it's a meaningful one. GLP-1 treatment is a titration journey — you start low and climb — so a plan that holds the price steady as the dose rises is structurally friendlier than one that doesn't, even if the starting numbers look similar on day one. Stack on no membership, HSA/FSA eligibility, and a clean cancel-anytime policy, and Mint Med reads like it was designed for people who want predictable, no-strings monthly costs rather than a relationship with a subscription dashboard.

Trust and oversight: solid signals, real gaps

On the verification side, Mint Med earns a high-confidence rating, and the reasons are concrete: it's LegitScript Certified with a directly verifiable ID, it enumerates all 36 states it serves by name, it publishes the FDA compounding disclaimer verbatim, and its cancellation and pricing terms are stated in plain language on the site. Mint Med does have an FDA warning letter on file, covered in the regulatory notice below. Those are strong primary signals, and they're why we trust the basics here. You can see how we weigh these factors in our scoring methodology.

That said, the transparency stops short in a few places worth knowing about. Mint Med does not name its 503A or 503B compounding pharmacy partner, doesn't disclose a named medical director or clinical leadership, and doesn't publish its corporate legal entity, governing law, arbitration venue, or a physical address. None of that is disqualifying — plenty of reputable platforms keep their pharmacy partner private — but if knowing exactly which pharmacy compounds your medication and who oversees the clinical program matters to you, you'll have to ask. There's also a tiny marketing inconsistency: the site says 35 states in one place but lists 36, which is cosmetic but the kind of sloppiness worth noticing.

Who should choose Mint Med — and who shouldn't

Choose it if you want the simplest possible cost structure: a single flat price that won't climb as your dose climbs, no membership, the freedom to cancel, and the bonus of paying with HSA/FSA funds. It's a strong fit for self-pay patients who are comfortable with compounded medication and an online-only, questionnaire-based intake.

Skip it if you specifically want brand-name Wegovy, Zepbound, Ozempic, or Mounjaro (Mint Med only does compounded), if you live outside its 36 states, or if you place a high value on a live video visit and on knowing your exact pharmacy and medical director by name before you commit. Those are reasonable dealbreakers, and Mint Med doesn't currently answer them.

Bottom line

Mint Med does one thing and does it cleanly: flat, predictable, membership-free pricing on compounded semaglutide and tirzepatide, backed by a verifiable LegitScript certification and honest FDA disclosures. The undisclosed pharmacy partner and clinical leadership keep it from being a perfect-transparency pick, and the asynchronous model won't suit everyone. But for a self-pay patient who wants a price that stays put as the dose goes up, it's a genuinely sensible, fairly priced option that sits below the category median.

Worth pricing against Brightmeds ($100/month) and Try Ageless ($119/month) before you commit — both sit close to Mint Med on cost and formulation.